Alembic Pharmaceuticals announced that the United States Food and Drug Administration (USFDA) had issued an establishment inspection report (EIR) for its oral solid formulation facility (F-1) located in Panelav, Gujarat. Read The Rest at :
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.
